1. A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Issue 1 (2nd January 2018) Authors: Tadmor, Tamar; Welslau, Manfred; Hus, Iwona Journal: Expert review of hematology Issue: Volume 11:Issue 1(2018) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Issue 1 (January 2016) Authors: Rummel, Mathias; Kaiser, Ulrich; Balser, Christina; Stauch, Martina; Brugger, Wolfram; Welslau, Manfred; Niederle, Norbert; Losem, Christoph; Boeck, Hans-Peter; Weidmann, Eckhart; von Gruenhagen, Ulrich; Mueller, Lothar; Sandherr, Michael; Hahn, Lars; Vereshchagina, Julia; Kauff, Frank; Blau, Wol... Journal: Lancet oncology Issue: Volume 17:Issue 1(2016:Feb.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First‐line nab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Results of the NEPTUN study. (20th October 2021) Authors: Dechow, Tobias; Riera‐Knorrenschild, Jorge; Hackanson, Björn; Janssen, Jan; Schulz, Holger; Chiabudini, Marco; Fischer von Weikersthal, Ludwig; Budweiser, Stephan; Nacke, Axel; Taeuscher, Dagmar; Welslau, Manfred; Potthoff, Karin Journal: Cancer medicine Issue: Volume 10:Number 22(2021) Page Start: 8127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients. (26th May 2020) Authors: Knauf, Wolfgang; Dingeldein, Gerrit; Schlag, Rudolf; Welslau, Manfred; Moehler, Thomas; Terzer, Tobias; Walter, Sarah; Habermehl, Christina; Kunz, Christina; Goldschmidt, Hartmut; Raab, Marc‐Steffen Journal: European journal of haematology Issue: Volume 105:Number 2(2020) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient‐reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T‐DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2–positive locally advanced or metastatic breast cancer. Issue 5 (12th November 2013) Authors: Welslau, Manfred; Diéras, Veronique; Sohn, Joo‐Hyuk; Hurvitz, Sara A.; Lalla, Deepa; Fang, Liang; Althaus, Betsy; Guardino, Ellie; Miles, David Journal: Cancer Issue: Volume 120:Issue 5(2014) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient‐reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T‐DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2–positive locally advanced or metastatic breast cancer. Issue 5 (12th November 2013) Authors: Welslau, Manfred; Diéras, Veronique; Sohn, Joo‐Hyuk; Hurvitz, Sara A.; Lalla, Deepa; Fang, Liang; Althaus, Betsy; Guardino, Ellie; Miles, David Journal: Cancer Issue: Volume 120:Issue 5(2014) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany. Issue 11 (6th September 2021) Authors: Singh, Prianka; McDonald, Laura; Waldenberger, Daniela; Welslau, Manfred; von der Heyde, Eyck; Gauler, Thomas; Dietz, Andreas Journal: Head & neck Issue: Volume 43:Issue 11(2021) Page Start: 3540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe. Issue 1 (6th November 2022) Authors: Bishton, Mark J.; Salles, Gilles; Golfier, Camille; Knauf, Wolfgang; Bocchia, Monica; Turner, Deborah; Slama, Borhane; Harchowal, Jatinder; Marshall, Scott; Bosi, Alberto; Lleonart, Juan José Bargay; Welslau, Manfred; Kim, SooKyoung; Lee, Young N.; Zinzani, Pier L.; Laribi, Kamel Journal: EJHaem Issue: Volume 4:Issue 1(2023) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape. (July 2017) Authors: Goebell, Peter J; Doehn, Christian; Grüllich, Carsten; Grünwald, Viktor; Steiner, Thomas; Ehneß, Rainer; Welslau, Manfred Journal: Future oncology Issue: Volume 13:Number 17(2017) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗